ISA Pharmaceuticals Overview
- Year Founded
-
2004
- Status
-
Private
- Employees
-
21
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$5M
- Investors
-
5
ISA Pharmaceuticals General Information
Description
Developer of synthetic therapeutic vaccines designed to provide treatment for cancer. The company's vaccines are based on proprietary synthetic long peptide technologies that provide treatment for cancer and persistent viral infections, enabling patients with treatment to have a likelihood of success.
Contact Information
Website
www.isa-pharma.comCorporate Office
- Leiden Bio Science Park
- De Limes 7
- 2342 DH Oegstgeest
- Netherlands
Corporate Office
- Leiden Bio Science Park
- De Limes 7
- 2342 DH Oegstgeest
- Netherlands
ISA Pharmaceuticals Timeline
ISA Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC | 15-Dec-2022 | $5M | Completed | Clinical Trials - Phase 2 | ||
| 7. Later Stage VC (Series B) | 06-Jul-2021 | Completed | Clinical Trials - Phase 2 | |||
| 6. Later Stage VC | 17-Jun-2020 | Completed | Clinical Trials - Phase 2 | |||
| 5. Debt - General | 28-Jun-2019 | Completed | Clinical Trials - General | |||
| 4. Secondary Transaction - Private | Completed | Clinical Trials - General | ||||
| 3. Later Stage VC | 07-Jan-2013 | Completed | Clinical Trials - General | |||
| 2. Grant | $27.3M | $14.8M | Completed | Startup | ||
| 1. Early Stage VC (Series A) | 01-Jan-2004 | $14.8M | $14.8M | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
ISA Pharmaceuticals Comparisons
Industry
Financing
Details
ISA Pharmaceuticals Competitors (8)
One of ISA Pharmaceuticals’s 8 competitors is Virometix, a Venture Capital-Backed company based in Schlieren, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Virometix | Venture Capital-Backed | Schlieren, Switzerland | ||||
| Gadeta | Formerly VC-backed | Utrecht, Netherlands | ||||
| Inotrem | Venture Capital-Backed | Paris, France | ||||
| F-Star Therapeutics | Formerly VC-backed | Cambridge, United Kingdom | ||||
| Theravectys | Venture Capital-Backed | Paris, France |
ISA Pharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
ISA Pharmaceuticals Patents
ISA Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230296569-A1 | Substance quantification in complex mixtures | Inactive | 12-Jul-2021 | ||
| EP-4370903-A1 | Improved substance quantification in complex mixtures | Pending | 12-Jul-2021 | ||
| CA-3223357-A1 | Improved substance quantification in complex mixtures | Pending | 12-Jul-2021 | ||
| JP-2024525690-A | Improved quantification of substances in complex mixtures | Pending | 12-Jul-2021 | ||
| EP-4138876-A1 | Immunization against sars-cov-related diseases | Pending | 23-Apr-2020 | C07K14/005 |
ISA Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
ISA Pharmaceuticals Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cancer Focus Fund | Venture Capital | Minority | ||
| Glass Frog Ventures | Angel Group | Minority | ||
| Invest-NL (Investment Company) | Impact Investing | Minority | ||
| Regeneron Pharmaceuticals | Corporation | Minority | ||
| De Hoge Dennen Capital | Family Office | Minority |
ISA Pharmaceuticals FAQs
-
When was ISA Pharmaceuticals founded?
ISA Pharmaceuticals was founded in 2004.
-
Where is ISA Pharmaceuticals headquartered?
ISA Pharmaceuticals is headquartered in Oegstgeest, Netherlands.
-
What is the size of ISA Pharmaceuticals?
ISA Pharmaceuticals has 21 total employees.
-
What industry is ISA Pharmaceuticals in?
ISA Pharmaceuticals’s primary industry is Drug Discovery.
-
Is ISA Pharmaceuticals a private or public company?
ISA Pharmaceuticals is a Private company.
-
What is ISA Pharmaceuticals’s current revenue?
The current revenue for ISA Pharmaceuticals is .
-
How much funding has ISA Pharmaceuticals raised over time?
ISA Pharmaceuticals has raised $84M.
-
Who are ISA Pharmaceuticals’s investors?
Cancer Focus Fund, Glass Frog Ventures, Invest-NL (Investment Company), Regeneron Pharmaceuticals, and De Hoge Dennen Capital have invested in ISA Pharmaceuticals.
-
Who are ISA Pharmaceuticals’s competitors?
Virometix, Gadeta, Inotrem, F-Star Therapeutics, and Theravectys are some of the 8 competitors of ISA Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
